FORA Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
FORA Capital's NVO Position: Q1 2026 in Review
FORA Capital sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 19,726 shares — an estimated $1.35M sold.
FORA Capital first reported a position in NVO in Q4 2019 and held it in 15 quarters. The position peaked at $5.31M in Q3 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- FORA Capital reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- FORA Capital sold 19,726 Novo Nordisk shares in Q1 2026, an estimated $1.35M.
- FORA Capital first reported a position in Novo Nordisk in Q4 2019 and held it in 15 quarters.
- FORA Capital's Novo Nordisk position peaked at $5.31M in Q3 2024.
- 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.